Stereotactic Radiotherapy of the Resection Cavity of Brain Metastases vs. Post-operative Whole-brain Radiotherapy
NCT03285932 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 56
Last updated 2022-11-03
Summary
In advanced cancer disease brain metastases are common, difficult to treat, and are associated with a poor prognosis. As new local and systemic therapies are eventually resulting in improved survival and quality of life for patients with brain metastases, negative neurocognitive effects of radiation therapy are becoming increasingly important as well as good loco-regional disease control of brain metastases.
Concerning treatment, brain metastases remain a major clinical problem and a multidisciplinary approach to management should be adopted. Neurosurgical resection with postoperative whole brain radiotherapy (WBRT) is one major treatment option in solitary or symptomatic brain metastases. Furthermore, WBRT is recommended for multiple brain metastases. For a limited number of brain metastases stereotactic radiosurgery (SRS) has been established as a highly effective treatment alternative.
Recently, a new treatment approach combing neurosurgery with postoperative stereotactic radiotherapy (SRT) of the resection cavity is emerging. Based on available evidence, postoperative SRT of the resection cavity improves local control following surgery, reduces the number of patients who require whole brain radiotherapy, and is well tolerated (1).
This protocol is aimed at primarily evaluating the safety and toxicity profile of SRT to the resection cavity following neurosurgical resection combined with SRT of potentially further unresected brain metastases, compared to postoperative whole-brain radiotherapy (WBRT). Secondary, the local effect of SRT in patients with brain metastases will be assessed by measuring time to local recurrence (LR), local and loco-regional progression-free survival (PFS).
Additional systemic treatment will be carried out according to the standards of the National Center for Tumor Therapy (NCT).
Conditions
- Brain Metastases, Adult
Interventions
- RADIATION
-
post-operative stereotactic radiosurgery (SRS)
For radiosurgery, patients will be immobilized. Treatment planning including the MRI and planning CT should be performed 1 -2 weeks before SRT and treatment finished at latest 3-4 weeks after surgery. Planning should be as close to SRT as possible. Organs at risk such as the brain stem, optic nerves, chiasm and spinal cord will be contoured. The Clinical Target Volume 1 (CTV1) will be defined as the resection cavity based on MRI and CT including T1 contrast enhanced changes around the resection cavity. The Clinical Target Volume 2 (CTV2) will be defined as a 3mm margin added to CTV1 by isotropic expansion and slightly adjusted as deemed appropriated by the experienced contouring physician. The Planning Target Volume (PTV) will be an additional margin of 1mm added to CTV2 by isotropic expansion. Treatment planning will be performed using Accuray's Multiplan or subsequent approved treatment planning systems for Cyberknife.
- RADIATION
-
Whole brain radiotherapy (WBRT)
For WBRT, an individual head fixation mask is manufactured for each patient, and treatment planning is performed as virtual simulation or 3D-conformal RT planning based on CT-imaging. The portals include the whole brain with special focus as including the skull base areas and lamina cribrosa. For low infratentorial lesions, the treatment volume may include the whole brain down to the second cervical vertbra. RT will be applied with two portals (e.g. 87°and 273°) using a 6 MeV linear accelerator. For WBRT, a total dose of 30 Gy in 3 Gy fractions will be applied.
Sponsors & Collaborators
-
Heidelberg University
collaborator OTHER -
Juergen Debus
lead OTHER
Principal Investigators
-
Juergen Debus, Prof. Dr. Dr. · Head of department Radiation Oncology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-01
- Primary Completion
- 2021-05-30
- Completion
- 2021-07-08
Countries
- Germany
Study Locations
More Related Trials
-
Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy
NCT02913534 ·Status: COMPLETED
-
Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases
NCT00581113 ·Status: TERMINATED ·Phase: PHASE3
-
Neurocognitive Outcome of Conformal WBRT w/wo Hippocampal Avoidance for Brain Metastases
NCT02393131 ·Status: UNKNOWN ·Phase: NA
-
Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain Metastases
NCT02265549 ·Status: COMPLETED
-
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
NCT03223922 ·Status: RECRUITING ·Phase: NA
-
Multicenter Retrospective Study on Patients Treated with Stereotactic Radiosurgery/Radiotherapy for Single Brain Lesions: Evaluation of Treatment Efficacy and Safety, Also Through Radiomic Analysis Methods.
NCT06869460 ·Status: ACTIVE_NOT_RECRUITING
-
MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy
NCT02031237 ·Status: COMPLETED
-
Neurocognitive Impact and Dose-Effect Relationship of Hippocampal Avoidance During Whole Brain Radiotherapy Plus Simultaneous Integrated Boost - A Prospective Follow-up Study
NCT03223675 ·Status: RECRUITING ·Phase: NA
-
Stereotactic Radiotherapy Management of Brain Metastases: the Value of a Longitudinal Multimodal Approach (POSTPONE)
NCT06029140 ·Status: UNKNOWN
-
Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
NCT01227954 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors
NCT00004659 ·Status: UNKNOWN ·Phase: PHASE2
-
A Prospective Study of the Impact of Hippocampal Avoidance During Whole Brain Radiotherapy on Neurocognitive Function Decline
NCT02504788 ·Status: RECRUITING ·Phase: NA
-
A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT
NCT04805255 ·Status: RECRUITING
-
Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain Metastases
NCT00138788 ·Status: COMPLETED ·Phase: PHASE3
-
Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor
NCT06929819 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy of the Association of Fractionated SRS and Subsequent Surgery in Patients With Brain Metastases
NCT06992973 ·Status: RECRUITING ·Phase: NA
-
Preop fSRS for Resectable Brain Metastases
NCT05267587 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Cognitive Outcome After Gamma Knife Radiosurgery in Patients With Brain Metastases (CAR-Study A)
NCT02953756 ·Status: COMPLETED
-
Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases
NCT01445483 ·Status: COMPLETED
-
Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases
NCT01731704 ·Status: WITHDRAWN ·Phase: NA
-
Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis
NCT01705548 ·Status: COMPLETED ·Phase: NA
-
Fractionated Stereotactic Radiosurgery for Large Brain Metastases
NCT02054689 ·Status: COMPLETED ·Phase: NA
-
Study of Resection Combined With Stereotactic Radiosurgery for 1 to 3 Brain Metastases
NCT00904553 ·Status: COMPLETED
-
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
NCT04033497 ·Status: RECRUITING ·Phase: NA
-
Surgery Versus Radiosurgery for the Treatment of Single Brain Metastases
NCT01295970 ·Status: WITHDRAWN ·Phase: NA